Tailored and seamless strategic guidance from molecule to market :

· Platform technology assessment

· Production, GMP & QA

· Viral safety, toxicology

· Technology licensing

· Preclinical & clinical developments

International registration, CE marking

Specific Expertise :

· New recombinant proteins, including transgenics

· Multisource recombinant proteins, including well-established use

· Therapeutic and diagnostic monoclonal antibodies

· Radio-Immuno-Therapeutics (RIT)

· Peptides, peptidomimetics

· Cell therapy, allo- and xeno- transplantation, vaccines

· Blood products including haemoglobin therapeutics

· Immediate & prolonged release formulations

· New chemical entities

Medical devices